Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft Model
- 1 July 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 8 (4) , 595-604
- https://doi.org/10.1021/bc970101v
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Overcoming the nephrotoxicity of radiometal-labeled immunoconjugatesCancer, 1997
- PretargetingCancer, 1997
- PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODELJournal of Immunotherapy, 1994
- Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude miceInternational Journal of Cancer, 1992
- The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-cea antibody in a human colonic tumor xenograft modelInternational Journal of Cancer, 1989
- Antibody protein dose and radioimmunodetection of gw‐39 human colon tumor xenograftsInternational Journal of Cancer, 1987